To confirm this finding, we refer to the study on 217 patients with CRC conducted by Mo Son et al. in 2019, that showed the percentage of FAP + CAF and α-SMA + CAFs in patients varied from 0% (in 4 patients) to98% and 23%, respectively [62]. The gene discussed is FAP; the disease is colorectal carcinoma.